MacGregor G A, Banks R A, Markandu N D, Bayliss J, Roulston J
Br Med J (Clin Res Ed). 1983 May 14;286(6377):1535-8. doi: 10.1136/bmj.286.6377.1535.
Increasing the dose of a thiazide diuretic used alone in patients with essential hypertension has little further effect on blood pressure but increases the deleterious metabolic consequences of the diuretic. The effect of a beta-blocker on this flat dose response is not known. In two randomised crossover studies the effect of 12.5 mg, 25 mg, and 50 mg hydrochlorothiazide combined with 400 mg acebutolol was assessed. The mean fall in supine blood pressure was about 15% and was the same whatever dose of thiazide was used with the beta-blocker. As the dose of hydrochlorothiazide was increased, however, there was evidence of increasing metabolic consequences of the diuretic. The study did not define the minimum dose of diuretic, and doses of hydrochlorothiazide lower than 12.5 mg might be as effective. These results suggest that many patients who are being treated with a combination of a beta-blocker and a diuretic are receiving unnecessarily large amounts of the diuretic without benefit to their blood pressure and with adverse metabolic consequences.
在原发性高血压患者中,单独增加噻嗪类利尿剂的剂量对血压的进一步影响很小,但会增加利尿剂有害的代谢后果。β受体阻滞剂对这种平稳剂量反应的影响尚不清楚。在两项随机交叉研究中,评估了12.5毫克、25毫克和50毫克氢氯噻嗪与400毫克醋丁洛尔联合使用的效果。仰卧位血压的平均降幅约为15%,无论与β受体阻滞剂一起使用的噻嗪类药物剂量如何,降幅都是相同的。然而,随着氢氯噻嗪剂量的增加,有证据表明利尿剂的代谢后果在增加。该研究未确定利尿剂的最小剂量,低于12.5毫克的氢氯噻嗪剂量可能同样有效。这些结果表明,许多正在接受β受体阻滞剂和利尿剂联合治疗的患者正在接受不必要的大剂量利尿剂,这对他们的血压没有益处,反而会产生不良代谢后果。